Evidence map›Paper›PMID 30893855›Full record

ArticleViruses2019

Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry Factors.

Francisco J Zapatero-Belinchón, Erik Dietzel, Olga Dolnik, Katinka Döhner, Rui Costa, Barbara Hertel, Barbora Veselkova, Jared Kirui, Anneke Klintworth, Michael P Manns and 8 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Francisco J Zapatero-BelinchónDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625 Hannover, Germany. ZapateroBelinchon.Francisco@mh-hannover.de.
Erik DietzelInstitute of Virology, Philipps University Marburg, 35043 Marburg, Germany. erik.dietzel@staff.uni-marburg.de.
Olga DolnikInstitute of Virology, Philipps University Marburg, 35043 Marburg, Germany. olga.dolnik@staff.uni-marburg.de.
Katinka DöhnerInstitute of Virology, Hannover Medical School, 30625 Hannover, Germany. Doehner.Katinka@mh-hannover.de.
Rui CostaDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625 Hannover, Germany. rui.costa@uk-essen.de.
Barbara HertelDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625 Hannover, Germany. bhertel@uni-potsdam.de.
Barbora VeselkovaInstitute of Virology, Hannover Medical School, 30625 Hannover, Germany. Veselkova.Barbora@mh-hannover.de.ORCID 0000-0002-2065-0946
Jared KiruiTWINCORE, Center for Experimental and Clinical Infection Research, Institute for Experimental Virology, 30625 Hannover, Germany. jared.kirui@twincore.de.
Anneke KlintworthDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625 Hannover, Germany. A.Klintworth@gmx.de.
Michael P MannsDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625 Hannover, Germany. Manns.Michael@mh-hannover.de.ORCID 0000-0002-4485-8856
Stefan PöhlmannInfection Biology Unit, German Primate Center ⁻ Leibniz Institute for Primate Research, 37077 Göttingen, Germany. SPoehlmann@dpz.eu.ORCID 0000-0001-6086-9136
Thomas PietschmannTWINCORE, Center for Experimental and Clinical Infection Research, Institute for Experimental Virology, 30625 Hannover, Germany. Pietschmann.Thomas@mh-hannover.de.
Thomas KreyGerman Center for Infection Research (DZIF) Hannover-Braunschweig Site, Germany. Krey.Thomas@mh-hannover.de.ORCID 0000-0002-4548-7241
Sandra CiesekInstitute of Virology, Essen University Hospital, 45122 Essen, Germany. Sandra.Ciesek@uk-essen.de.
Gisa GeroldTWINCORE, Center for Experimental and Clinical Infection Research, Institute for Experimental Virology, 30625 Hannover, Germany. gisa.gerold@twincore.de.
Beate SodeikGerman Center for Infection Research (DZIF) Hannover-Braunschweig Site, Germany. Sodeik.Beate@mh-hannover.de.ORCID 0000-0003-4650-3036
Stephan BeckerInstitute of Virology, Philipps University Marburg, 35043 Marburg, Germany. becker@staff.uni-marburg.de.
Thomas von HahnDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625 Hannover, Germany. vonhahn.thomas@mh-hannover.de.ORCID 0000-0002-1233-0379
Medizinische Hochschule Hannover · DECenter for Experimental and Clinical Infection Research · DEPhilipps University of Marburg · DEEssen University Hospital · DEGerman Primate Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Filoviruses infect a wide range of cell types with the exception of lymphocytes. The intracellular proteins cathepsin B and L, two-pore channel 1 and 2, and bona fide receptor Niemann⁻Pick Disease C1 (NPC1) are essential for the endosomal phase of cell entry. However, earlier steps of filoviral infection remain poorly characterized. Numerous plasma membrane proteins have been implicated in attachment but it is still unclear which ones are sufficient for productive entry. To define a minimal set of host factors required for filoviral glycoprotein-driven cell entry, we screened twelve cell lines and identified the nonlymphocytic cell line SH-SY5Y to be specifically resistant to filovirus infection. Heterokaryons of SH-SY5Y cells fused to susceptible cells were susceptible to filoviruses, indicating that SH-SY5Y cells do not express a restriction factor but lack an enabling factor critical for filovirus entry. However, all tested cell lines expressed functional intracellular factors. Global gene expression profiling of known cell surface entry factors and protein expression levels of analyzed attachment factors did not reveal any correlation between susceptibility and expression of a specific host factor. Using binding assays with recombinant filovirus glycoprotein, we identified cell attachment as the step impaired in filovirus entry in SH-SY5Y cells. Individual overexpression of attachment factors T-cell immunoglobulin and mucin domain 1 (TIM-1), Axl, Mer, or dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) rendered SH-SY5Y cells susceptible to filovirus glycoprotein-driven transduction. Our study reveals that a lack of attachment factors limits filovirus entry and provides direct experimental support for a model of filoviral cell attachment where host factor usage at the cell surface is highly promiscuous.

Indexed as

Host-Pathogen InteractionsVirus InternalizationA549 CellsCarrier ProteinsCell LineCell MembraneEbolavirusFiloviridaeGene Expression ProfilingHEK293 CellsHumansMembrane GlycoproteinsReceptors, VirusViral ProteinsCarrier ProteinsMembrane GlycoproteinsReceptors, VirusViral Proteinsattachment factors redundancyFilovirus cell entryhost–pathogen interactionsSH-SY5Y cell line

Identifiers

PMID30893855
PMCPMC6466046
OpenAlexW2923598246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.